MARKET

LHDX

LHDX

Lucira Health, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.900
-0.400
-7.55%
After Hours: 4.900 0 0.00% 19:01 01/21 EST
OPEN
5.18
PREV CLOSE
5.30
HIGH
5.18
LOW
4.770
VOLUME
378.24K
TURNOVER
--
52 WEEK HIGH
37.99
52 WEEK LOW
4.230
MARKET CAP
175.75M
P/E (TTM)
-2.5225
1D
5D
1M
3M
1Y
5Y
USPS begins shipping free at-home COVID-19 rapid tests
The United States Postal Service yesterday began shipping out free rapid COVID-19 tests to homes across the country. At a briefing today, White House COVID-19 Response Coordinator Jeffrey Zients said
Seekingalpha · 12h ago
28 Stocks Moving In Wednesday's Mid-Day Session
Gainers Immuron Limited (NASDAQ: IMRN) shares jumped 40.2% to $3.5887. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing regimen for Travelan more suited for use by the military.
Benzinga · 01/12 17:00
Roche to offer 'tens of millions' of at-home Covid tests by end of month
The rollout comes amid long lines at testing sites and President Joe Biden's promise to increase the number of tests available.
American City Business Journals · 01/11 16:20
Lucira Announces The Check-It PCR-Quality, At-Home Molecular COVID-19 Test Now Available In The Optum Store
Lucira's COVID-19 test is the only EUA authorized rapid at-home self-test that delivers PCR accuracy and early detectability in a single-use test kit with results in 30 minutes Availability in the Optum Store
Benzinga · 01/11 12:00
Lucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test Now Available in the Optum Store
Lucira's COVID-19 test is the only EUA authorized rapid at-home self-test that delivers PCR accuracy and early detectability in a single-use test kit with results in 30 minutes Availability in the Optum Store expands access to this unique testing option am...
GlobeNewswire · 01/11 12:00
60 Biggest Movers From Yesterday
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday.
Benzinga · 01/11 09:52
Private health insurers must cover up to 8 at-home COVID tests per month per person
Beginning Jan. 15, private health insurers must cover the cost of up to eight at-home COVID-19 tests for each covered member, according to a new requirement from the Biden administration.
Seekingalpha · 01/10 22:57
45 Stocks Moving In Monday's Mid-Day Session
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88.
Benzinga · 01/10 17:14
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LHDX. Analyze the recent business situations of Lucira Health, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
66.67%Hold
33.33%Under-perform
0.00%Sell
Analyst Price Target
The average LHDX stock price target is 8.00 with a high estimate of 9.00 and a low estimate of 7.00.
High9.00
Average8.00
Low7.00
Current 4.900
EPS
Actual
Estimate
-0.46-0.34-0.23-0.11
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 36
Institutional Holdings: 17.74M
% Owned: 49.45%
Shares Outstanding: 35.87M
TypeInstitutionsShares
Increased
13
1.50M
New
10
988.24K
Decreased
8
345.40K
Sold Out
18
659.60K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.93%
Healthcare Equipment & Supplies
-1.50%
Key Executives
President/Chief Executive Officer/Director
Erik Engelson
Chief Financial Officer/Treasurer
Daniel George
Chief Operating Officer
Hansgregory Hartmann
Executive Vice President
Ghazi Kashmolah
Executive Vice President
Kelly Lewis Brezoczky
Chief Technology Officer
Debkishore Mitra
Vice President - Operations
Tamanna Prashar
Independent Director
Sandra Gardiner
Independent Director
David Lamond
Independent Director
Erica Rogers
Independent Director
Lior Susan
Independent Director
Steve Tablak
Independent Director
Tuff Yen
No Data
About LHDX
Lucira Health, Inc. is medical technology company. The Company is focused on the development and commercialization of transformative and infectious disease test kits. The Company has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and test kit that is powered by two AA batteries and fit in the palm of a hand. Its initial focus is within respiratory diseases, starting with COVID-19 and influenza A and B virus indications. It has developed LUCIRA COVID-19 All-In-One Test Kit (COVID-19 test kit), is a single-use, molecular in vitro diagnostic test that has an analytical sensitivity to detect the SARS-CoV-2 virus. The test is authorized for prescription at-home use.

Webull offers kinds of Lucira Health Inc stock information, including NASDAQ:LHDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LHDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LHDX stock methods without spending real money on the virtual paper trading platform.